$GIANT BIOGENE(02367)$ 2367巨子生

26
1
Favorite

盲炳
2025-06-06

$GIANT BIOGENE(02367)$ 2367巨子生物股价出现了明显回调，较历史高点已回撤近三成。从财务数据来看，公司资产负债表健康，现金资产高、无有息负债，且运营高效，收入增速高，盈利能力强。尽管当下因旗下可复美成分含量争议，股价有所波动，但公司已多次回应并提供检测数据自证。从业务层面，24 - 25年其两大品牌可复美、可丽金表现亮眼，且有多品线、品牌储备。随着后续新品放量以及医美领域新产品获批上市，业绩有望持续增长。当前回调幅度已较为充分，已具备一定安全边际，是开启建仓的合适时机，可逐步布局，把握长期投资价值。

02367

06-06 14:59

HKGIANT BIOGENE

Side	Price \| Filled	Realized P&L
Buy Open	59.35 2,000	-- Closed

GIANT BIOGENE

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Top
Latest

DeltaDrift
·2025-06-09
如果对其基本面有信心，当前的回调确实是布局的好时机。
Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":443067382509664,"tweetId":"443067382509664","gmtCreate":1749193223223,"gmtModify":1749459566973,"author":{"id":4160043317841132,"idStr":"4160043317841132","authorId":4160043317841132,"authorIdStr":"4160043317841132","name":"盲炳","avatar":"https://community-static.tradeup.com/news/b36a6c05b78a7183f709007b5caf47ac","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":13,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.15","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.20","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":634,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":464,"starInvestorOrderShareNum":1293,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":94.18,"showRor":true,"investmentPhilosophy":"日日難過日日過，天天難贏天天驘!","winRationPercentage":87.448047,"tradeVolumeEst":0},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/02367\">$GIANT BIOGENE(02367)$&nbsp;</a>2367巨子生物股价出现了明显回调，较历史高点已回撤近三成 。从财务数据来看，公司资产负债表健康，现金资产高、无有息负债，且运营高效，收入增速高，盈利能力强。尽管当下因旗下可复美成分含量争议，股价有所波动，但公司已多次回应并提供检测数据自证。从业务层面，24 - 25年其两大品牌可复美、可丽金表现亮眼，且有多品线、品牌储备。随着后续新品放量以及医美领域新产品获批上市，业绩有望持续增长。当前回调幅度已较为充分，已具备一定安全边际，是开启建仓的合适时机，可逐步布局，把握长期投资价值。</body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/02367\">$GIANT BIOGENE(02367)$&nbsp;</a>2367巨子生物股价出现了明显回调，较历史高点已回撤近三成 。从财务数据来看，公司资产负债表健康，现金资产高、无有息负债，且运营高效，收入增速高，盈利能力强。尽管当下因旗下可复美成分含量争议，股价有所波动，但公司已多次回应并提供检测数据自证。从业务层面，24 - 25年其两大品牌可复美、可丽金表现亮眼，且有多品线、品牌储备。随着后续新品放量以及医美领域新产品获批上市，业绩有望持续增长。当前回调幅度已较为充分，已具备一定安全边际，是开启建仓的合适时机，可逐步布局，把握长期投资价值。</body></html>","text":"$GIANT BIOGENE(02367)$ 2367巨子生物股价出现了明显回调，较历史高点已回撤近三成 。从财务数据来看，公司资产负债表健康，现金资产高、无有息负债，且运营高效，收入增速高，盈利能力强。尽管当下因旗下可复美成分含量争议，股价有所波动，但公司已多次回应并提供检测数据自证。从业务层面，24 - 25年其两大品牌可复美、可丽金表现亮眼，且有多品线、品牌储备。随着后续新品放量以及医美领域新产品获批上市，业绩有望持续增长。当前回调幅度已较为充分，已具备一定安全边际，是开启建仓的合适时机，可逐步布局，把握长期投资价值。","highlighted":1,"essential":1,"paper":1,"likeSize":26,"commentSize":1,"repostSize":7,"favoriteSize":0,"link":"https://ttm.financial/post/443067382509664","repostId":0,"isVote":1,"tweetType":1,"viewCount":2458,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02367"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4160043317841132","orderId":"39360130992328704","kind":"TRADE","symbol":"02367","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/02367\">$GIANT BIOGENE(02367)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/02367","symbolName":"GIANT BIOGENE","market":"HK","action":"BUY","currency":"HKD","symbolLogo":"","showFilledQuantity":true,"nameCN":"GIANT BIOGENE","orderType":"LMT","filledQuantityFinal":2000,"avgFillPrice":59.35,"createTime":1749193180,"filledQuantity":"2000","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"GIANT BIOGENE","contractExtraDescription":"02367","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0.0083},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":445,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":444240936477208,"commentId":"444240936477208","gmtCreate":1749459565716,"gmtModify":1749463602679,"authorId":10000000000011028,"author":{"id":10000000000011028,"idStr":"10000000000011028","authorId":10000000000011028,"name":"DeltaDrift","avatar":"https://community-static.tradeup.com/news/11d675a610354289230d3a2f6c6e4c88","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":443067382509664,"objectIdStr":"443067382509664","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"如果对其基本面有信心，当前的回调确实是布局的好时机。","text":"如果对其基本面有信心，当前的回调确实是布局的好时机。","html":"如果对其基本面有信心，当前的回调确实是布局的好时机。","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}